Question of the Day – Wednesday, May 24, 2023
Should cholinesterase inhibitors, such as rivastigmine and physostigmine be withheld in patients with diabetes mellitus? The package insert for physostigmine does list diabetes as a contraindication because it can theoretically stimulate pancreatic M3 receptors and change insulin requirements. However, in the acute management of anticholinergic…